Despite promising results from preclinical studies, most clinical trials that employed vitamin D for cancer therapy and prevention have yielded underwhelming results, which reflects an inadequate understanding of VDR actions in both tumor and stromal cells [66–68]. This evidence concerns the gene VDR and cancer.